Elobixibat (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Elobixibat" in English language version.

refsWebsite

Global rank English rank

2albireopharma.com

low place

low place

4^th place

4^th place

1web.archive.org

1^st place

1^st place

2^nd place

2^nd place

1pharmatimes.com

low place

low place

14^th place

14^th place

albireopharma.com

"INN for A3309 is ELOBIXIBAT". AlbireoPharma. Archived from the original on 18 January 2012. Retrieved 5 December 2012.
"Ajinomoto Pharmaceuticals and Albireo Announce Japan and Asia License Agreement for Elobixibat". Albireo. Archived from the original on 16 January 2013. Retrieved 5 December 2012.

archive.today

"Ajinomoto Pharmaceuticals and Albireo Announce Japan and Asia License Agreement for Elobixibat". Albireo. Archived from the original on 16 January 2013. Retrieved 5 December 2012.

doi.org

Acosta A, Camilleri M (2014). "Elobixibat and its potential role in chronic idiopathic constipation". Therap Adv Gastroenterol. 7 (4): 167–75. doi:10.1177/1756283X14528269. PMC 4107709. PMID 25057297.

nih.gov

ncbi.nlm.nih.gov

Acosta A, Camilleri M (2014). "Elobixibat and its potential role in chronic idiopathic constipation". Therap Adv Gastroenterol. 7 (4): 167–75. doi:10.1177/1756283X14528269. PMC 4107709. PMID 25057297.

pubmed.ncbi.nlm.nih.gov

Acosta A, Camilleri M (2014). "Elobixibat and its potential role in chronic idiopathic constipation". Therap Adv Gastroenterol. 7 (4): 167–75. doi:10.1177/1756283X14528269. PMC 4107709. PMID 25057297.

pharmatimes.com

Grogan, Kevin (4 July 2012). "Ferring acquires rights to Albireo's bowel drug". PharmaTimes. Retrieved 23 March 2017.

web.archive.org

"INN for A3309 is ELOBIXIBAT". AlbireoPharma. Archived from the original on 18 January 2012. Retrieved 5 December 2012.